Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA -- Ignore unavailable to you. Want to Upgrade?

To: james bravick who wrote (51)	4/16/1999 12:01:00 AM
From: gcrispin	Read Replies (1) \| Respond to of 253

Anyone care to compare KERA and STAA?

To: james bravick who wrote (51)	4/16/1999 1:32:00 AM
From: Joe	Read Replies (1) \| Respond to of 253

Jim I heard it from someone in their booth at ASCRS. The person that said it is someone that would have direct, first hand knowledge (I'm not going to name names). He did not say what the numbers were. He also mentioned there would be a couple of good news releases - turned out to be the LCAV deal and the hyperopia release. So that gives his other statement on good numbers some credibility. He was a little defensive when he said these things, so take it for what it's worth. Joe